Table 3 The difference between good prognosis and poor prognosis

Mean age (years)

33.0(22.0,50.0)

42.0(23.0,56.5)

-2.0

0.041*

Male (%)

80(65.6%)

40(61.5%)

0.3

0.584

Onset time (days)

3.5(2.0,7.0)

4.0(2.0,8.5)

-1.3

0.183

Hospitalized days

18.0(11.0,29)

19.0(8.5,48.0)

-0.4

0.706

Admission to ICU (days)

6.0(3.0,11.0)

6.0(2.0,18.5)

-0.9

0.386

Days of critical condition

8.0(4.0,14.0)

16.0(5.0,30.5)

-2.6

0.010*

Number of rescuing

0.0(0.0,0.0)

0.0(0.0,2.5)

-3.9

<0.001*

Days of advanced care

5.0(3.0,9.0)

8.0(3.0,20.0)

-2.0

0.044*

Days of primary care

14.0(7.0,21.5)

12.0(6.0,30.5)

-0.3

0.771

CSFP

 CSFP ≥ 180mmH₂O

54(44.3%)

35(54.7%)

1.8

0.175

 CSFP ≥ 400mmH₂O

14(11.5%)

11(17.2%)

1.2

0.278

White blood cell in CSF>10/uL

80(65.6%)

44(67.7%)

0.1

0.770

White blood cell in CSF>500/uL

20(16.4%)

5(7.7%)

2.8

0.096

Total protein in CSF>0.4 g/L

81(66.4%)

42(64.6%)

0.1

0.807

Total protein in CSF>1 g/L

31(25.4%)

23(35.4%)

2.1

0.152

Abnormal imaging

34(28.6%)

29(46.8%)

6.0

0.015*

Abnormal electroencephalogram

35(29.9%)

17(27.9%)

0.1

0.776

Complication

57(46.7%)

39(60.0%)

3.0

0.084

Causative agent

 Viral

94(77.0%)

41(63.1%)

15.0

0.002*

 Bacterial

22(18.0%)

9(13.8%)

 Fungal

3(2.5%)

4(6.2%)

 Tubercular

3(2.5%)

11(16.9%)